WINNERS & LOSERS: Time Finance backs buyout; Nostrum sells assets
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
| Price | 3.99p on 21-08-2026 at 18:35:09 |
|---|---|
| Change | 0.24p 6.4% |
| Buy | 3.99p |
| Sell | 3.41p |
| Last Trade: | Buy 114.00 at 3.99p |
| Day's Volume: | 1,248,999 |
| Last Close: | 3.99p |
| Open: | 3.55p |
| ISIN: | GB0033711010 |
| Day's Range | 3.435p - 3.99p |
| 52wk Range: | 1.51p - 19.00p |
| Market Capitalisation: | £24.89m |
| VWAP: | 3.54849p |
| Shares in Issue: | 623.91m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Immupharma (IMM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 114 | 3.99p | Suspected BUY Trade |
16:45:52 - 21-Aug-26 |
| Buy* | 26,373 | 3.7917p | Ordinary |
16:25:18 - 21-Aug-26 |
| Sell* | 60,000 | 3.5948p | Ordinary |
16:14:12 - 21-Aug-26 |
| Buy* | 16,911 | 3.4887p | Ordinary |
16:08:45 - 21-Aug-26 |
| Buy* | 25,600 | 3.4923p | Ordinary |
16:03:23 - 21-Aug-26 |
| Sell* | 2,107 | 3.435p | Automatic Execution |
16:00:12 - 21-Aug-26 |
| Sell* | 50,000 | 3.44p | Automatic Execution |
16:00:12 - 21-Aug-26 |
| Sell* | 72,080 | 3.4753p | Ordinary |
16:00:05 - 21-Aug-26 |
| Sell* | 11,000 | 3.4753p | Ordinary |
15:53:51 - 21-Aug-26 |
| Sell* | 11,581 | 3.4753p | Ordinary |
15:48:16 - 21-Aug-26 |
Immupharma (IMM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Aug 2026 7:00 am | RNS | Bioanalytical CRO partner for Kapiglucagon |
| 22nd Jul 2026 7:00 am | RNS | Thermo Fisher CDMO selected for Kapiglucagon pro |
| 25th Jun 2026 1:20 pm | RNS | 2026 RESULT OF ANNUAL GENERAL MEETING |
| 25th Jun 2026 7:00 am | RNS | ImmuPharma appoints Bachem for Kapiglucagon API |
| 24th Jun 2026 7:00 am | RNS-R | University of Murcia research relating to P140 |
| 4th Jun 2026 7:10 am | RNS-R | Incanthera plc – Corporate Update & Board Changes |
| 2nd Jun 2026 7:00 am | RNS | Notice of AGM & Annual Report & Accounts |
| 27th May 2026 7:00 am | RNS | Final Results |
| 5th May 2026 7:00 am | RNS | IMM initiatesIND-Enabling Program for Kapiglucagon |
| 10th Apr 2026 7:00 am | RNS | Holding(s) in Company |